Results 1 to 10 of about 63,911 (206)
Troubleshooting in extracorporeal life support. [PDF]
Swiss Medical Weekly, 2015 Since the first clinical use of extracorporeal circulation in the last century [1] by John Gibbon and the first successful mechanical support of the left ventricular function by Forest Dodrill [2], the progress of techniques and technologies has helped ...
Berdajs, D.
core +4 more sources
Extracorporeal Life Support [PDF]
Air Medical Journal, 2015 This is a review of the University of Michigan experience with extracorporeal life support (ECLS) also known as extracorporeal membrane oxygenation (ECMO). Two thousand patients were managed with ECMO from 1973 to 2010. The first 1,000 patients were reported previously.
Ghislaine, Douflé +2 more
+8 more sources
A Portable Servoregulation Controller to Automate CO2 Removal in Artificial Lungs
Bioengineering, 2022 Artificial lung (AL) systems provide respiratory support to patients with severe lung disease, but none can adapt to the changing respiratory needs of the patients.
Navid Shaikh +8 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 ObjectivesThis study aims to explore the pathogen-detected effect of mNGS technology and its clinical application in non-immunocompromised patients with severe pneumonia supported by vv-ECMO.MethodsA retrospective analysis was conducted on a cohort of 50
Xing-Xing Li +6 more
doaj +1 more source
Frontiers in Medicine, 2022 ObjectivesExtracorporeal membrane oxygenation (ECMO) patients with or without transport both have high hospital mortality rate and there are few data on adult VA-ECMO transport patients.
Yang-Chao Zhao +7 more
doaj +1 more source
Organ damage evaluation in a temperature-controlled circulatory arrest rat model
BMC Cardiovascular Disorders, 2022 Background Deep hypothermic circulatory arrest (DHCA) is commonly used in adult aortic surgery and pediatric complex congenital heart disease, and is associated with pathophysiological changes and postoperative complications.
Yaoyao Xiong +4 more
doaj +1 more source
CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis
Frontiers in Immunology, 2023 BackgroundAfter its approval by the European Union in 2011, CytoSorb therapy has been applied to control cytokine storm and lower the increased levels of cytokines and other inflammatory mediators in blood.
Shilin Wei +13 more
doaj +1 more source
Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease
Frontiers in Immunology, 2023 AimThe present study aimed to evaluate the durability of immune response after basic and booster immunization with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with chronic liver disease (CLD).MethodsPatients with CLD
Ruixin Song +20 more
doaj +1 more source
Immunity, Inflammation and Disease, 2023 Objective The aim of this study was to elucidate the mechanism of beraprost sodium (BPS) in the intervention of myocardial fibrosis after myocardial infarction (MI) through glycogen synthase kinase‐3β (GSK‐3β) and to provide new ideas for intervention in
Xing‐Xing Li +5 more
doaj +1 more source